Occult metastases in patients with breast cancer

Annals of Surgical Oncology

Volumn 8, Issue 9 SUPPL., 2001, Pages 60-63

  Hawes, D ^a   Munro Neville, A ^a   Cote, R J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW METASTASIS; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; MOLECULAR BIOLOGY; OCCULT CANCER;

BONE MARROW NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034773842     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Rationale for adjuvant chemotherapy
2. Detection of micrometastases in patients with primary breast cancer
3. Immunohistochemical detection of occult carcinoma in bone marrow and blood
4. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system
5. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
6. Bone metastasis in breast cancer
7. Monoclonal antibodies detect occult breast carcinoma metastases in bone marrow of patients with early-stage disease
8. Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases
9. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
10. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
11. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
12. The reliability of histologically negative axillary lymph nodes in breast cancer
13. Prognostic factors and primary breast cancer
14. Detection and significance of occult axillary node metastases in patients with invasive breast cancer
15. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast cancer - A study of 97 cases
16. The use of monoclonal antibodies for the histological detection of mammary axillary micrometastases
17. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
18. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up
19. Micrometastases to axillary lymph nodes from carcinoma of the breast: Detection by immunohistochemistry and prognostic significance
20. Detection and significance of occult metastases in node-negative breast cancer
21. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
22. Advances in the pathologic staging of lung cancer: Detection of regional and systemic occult metastases